Search
for
Sort by
Research 541–570 of 1000+
- Optimizing hair transplant outcomes: integration of AI, robotics, and stem cell therapies
- Skin-inspired phototherapeutic cryogel ameliorates infected wound healing by orchestrating mechanotransduction and immunomodulation
- Catechins-rich tea extract and its functional properties mitigating hair loss
- Effect of Cuscuta reflexa Extract in Mitigating Testosterone-Induced Benign Prostatic Hyperplasia in Rats: Targeting Inflammation and Oxidative Stress
- SesZen-Bio: A Novel Modulator of Wnt/β-Catenin Signalling for Promoting Hair Growth and Follicular Regeneration
- The Role of Sex Hormones in Skin Health
- Hybrid hair follicle stem cell extracellular vesicles co-delivering finasteride and gold nanoparticles for androgenetic alopecia treatment
- Identification of a human type XVII collagen fragment with high capacity for maintaining skin health
- Use of Low Level Laser in Cosmetic Dermatology
- Development of novel wound dressing based on elastin-like recombinamers for skin regeneration
- Development and Invitro Evaluation of Solid Lipid Nano Particles Loaded Topical Gel Containing Combination of Drugs Used In The Better Therapy of Psoriasis
- Human bone marrow mesenchymal stem cells-derived exosomes stimulate cutaneous wound healing mediates through TGF-β/Smad signaling pathway
- Phytochemicals as emerging therapeutic agents for alopecia treatment
- 1380 PPAR-γ modulation as a novel therapeutic strategy for scarring alopecia
- Australasian Society for Dermatology Research Meeting, May 2006
- The role of integrin alphavbeta6 in impaired wound healing and hair follicle regeneration
- Development of a Chitosan Nanofibrillar Scaffold for Skin Repair and Regeneration
- ACNE
- Current and future pharmacotherapy for alopecia areata
- Role of oral minoxidil in patterned hair loss
- Nrf2-Mediated Expansion of Pilosebaceous Cells Accelerates Cutaneous Wound Healing
- Dynamic expression of Runx1 in skin affects hair structure
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Activation of Nrf2 in keratinocytes causes chloracne (MADISH)‐like skin disease in mice
- NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
- Targeted delivery of extracellular vesicles: the mechanisms, techniques and therapeutic applications
- Proteolysis‐targeting chimeras in cancer therapy: Targeted protein degradation for next‐generation treatment
- Microneedles as an Emerging Platform for Transdermal Delivery of Phytochemicals
- Identification of a new plant extract for androgenic alopecia treatment using a non-radioactive human hair dermal papilla cell-based assay
- Methods and Challenges in Purifying Drug‐Loaded Extracellular Vesicles